Drug Developement/Delivery
- GLP-1R Agonists for Weight Loss
- PROTACs VS. Traditional Small Molecule Inhibitors
- Summary of PROTAC Degraders in Clinical Trials
- Hydrogels: History & Application in Drug Delivery
- Peptide PROTAC in Drug Development
- FDA Approves Tirzepatide, A Potential Blockbuster Drug for Type 2 Diabetes
- Anti-Cancer Peptide Drug Conjugates (PDCs): An Overview
- Anti-obesity Medications (AOMs): History And Progress
- Overview of Antidiabetic Drug Classifications and Future Trends
- FDA Approves Besremi (ropeginterferon alfa-2b-njft) for Treating Polycythemia Vera